Japanese Tobacco Stock News

E J Holdings Inc. ( TSE:2153 ) just released a solid earnings report, and the stock displayed some strength. Despite...

Investors were underwhelmed by the solid earnings posted by Nachi-Fujikoshi Corp. ( TSE:6474 ) recently. Our analysis...

Earlier this month, Comforia Residential REIT announced the acquisition of five domestic residential assets, the issuance of 107,620 new investment units via a follow-on equity offering, and an upward revision to its operating and profit forecasts for the period ending January 31, 2027. An interesting aspect of the announcement is how the asset acquisitions and equity issuance are directly tied to updated earnings assumptions based on current rental residence market conditions. Next, we will...

Olympus Corporation has appointed Brian Barry as Executive Officer and Chief Quality Officer, succeeding Boris Shkolnik, following a Board resolution effective August 1, 2026, marking a leadership transition in the company’s global quality and regulatory function. This move brings in a leader with more than 40 years of experience across global Quality, Regulatory Affairs, Medical Safety, and Clinical Affairs, underlining Olympus’s focus on strengthening quality systems, patient safety, and...

Aeon Co., Ltd. reported Q1 2027 results on July 10, 2026, with sales of ¥2,702,257 million, revenue of ¥2,941,981 million, and net income of ¥13,809 million, marking a return to profitability versus a loss a year earlier. The swing from a basic loss per share of ¥2.54 to earnings of ¥4.99 from continuing operations highlights a sharp improvement in Aeon’s underlying performance. We’ll now examine how Aeon’s return to profitability and higher revenue in Q1 2027 may reshape its existing...

With inflation risks tied to energy markets, shifting central bank expectations, and uneven global growth, many investors are looking for companies that still have clear earnings growth potential and solid balance sheets. The Healthy high growth potential screener focuses on stocks that analysts expect to grow earnings strongly over the next 3 years and that also meet basic financial health checks. That combination can help you focus on businesses where growth expectations are backed by an...

Teijin stock reaction and recent performance With no single headline event driving Teijin (TSE:3401) today, investors are focusing on the stock’s recent returns, its current valuation signals, and how its diversified materials and healthcare exposure might fit into portfolios. See our latest analysis for Teijin. Recent trading reflects that Teijin’s share price return of 5.9% over the past month and 25.9% year to date has been strong, while the 1 year total shareholder return of 45.4% points...

In recent weeks, Asian markets have experienced significant volatility, with technology stocks facing downward pressure amid concerns over valuations and geopolitical tensions. Despite these challenges, the region presents opportunities for investors seeking undervalued stocks that may offer potential value based on current market conditions. Identifying such stocks requires a careful analysis of financial health, growth prospects, and market positioning within the broader economic landscape.

Toho Co., Ltd. reported past first-quarter 2026 results with sales of ¥88,742 million, up from ¥84,878 million a year earlier, while net income fell to ¥8,196 million from ¥11,565 million and basic earnings per share declined to ¥9.81 from ¥13.64. At the same time, Toho issued full-year 2027 earnings guidance and its board met to consider a new policy on reducing strategic shareholdings, signaling potential shifts in capital allocation and portfolio management. With recent share price gains,...

ERI Holdings Co., Ltd. ( TSE:6083 ) recently posted some strong earnings, and the market responded positively. We did...

The market for Enjin Co., Ltd.'s ( TSE:7370 ) shares didn't move much after it posted weak earnings recently. We did...

Sotetsu Holdings (TSE:9003) has drawn fresh attention after setting the terms for its 47th unsecured bond issue, a ¥10.0b, 10 year offering carrying a 3.224% annual coupon and general public placement. See our latest analysis for Sotetsu Holdings. For context, Sotetsu Holdings’ share price has risen 8.07% over the past month but is down 9.37% over the past quarter, while its 1 year total shareholder return of 14.59% points to momentum building over a longer horizon. If this bond issue has you...

Eisai and Biogen recently reported real-world data from the three-year LEADER study showing that nearly 83% of early Alzheimer’s patients on Leqembi remained stable or improved over about 17 months, and secured U.S. FDA approval for once-weekly subcutaneous Leqembi Iqlik as an at-home initiation option. These updates suggest that Leqembi’s convenience, persistence on therapy and consistency across diverse patient groups could be increasingly important drivers of its clinical and commercial...

Ichigo Q1 2027 earnings call as a fresh catalyst Ichigo (TSE:2337) recently released its Q1 2027 pre recorded earnings call on July 15, 2026, giving investors fresh information on its real estate, hotel, and clean energy businesses in Japan. See our latest analysis for Ichigo. Ichigo's Q1 2027 earnings update comes after a mixed share price pattern, with the stock up 4.11% over the last day but down 15.98% over 90 days. Meanwhile, 1 year and 3 year total shareholder returns of 17.47% and...

Why the FDA sNDA for cefiderocol matters for Shionogi stock The FDA sNDA acceptance for Shionogi (TSE:4507) antibiotic cefiderocol in pediatric hospital and urinary infections highlights a fresh regulatory milestone that could influence how investors think about the company s long term revenue mix. See our latest analysis for Shionogi. Investors have seen Shionogi s share price gain 3.45% over the past month, even after a roughly 10.49% decline over 90 days. At the same time, the 1 year total...

In July 2026, Yamato Holdings Co., Ltd. established a "Corporate Value Enhancement Committee," a six-member advisory body under the Board composed mainly of outside directors and chaired by President Toshiyuki Sakurai to focus on maximizing corporate value. This new committee, sitting alongside Yamato’s existing nomination, compensation, compliance, and risk bodies, signals a reinforced governance framework centered on independent oversight of long-term value creation. We will now explore...

MediPal Holdings (TSE:7459) has updated investors with higher full year dividend guidance and revised earnings expectations after completing its tender offer for PALTAC Corporation, which shifts more of PALTAC's profit fully onto its books. See our latest analysis for MediPal Holdings. Recent moves suggest growing interest in MediPal Holdings, with a 1 month share price return of 9.92% and a 1 year total shareholder return of 19.90%. This points to building momentum around the revised...

Tsuruha Holdings Inc. previously reported first-quarter 2026 results, with sales rising to ¥636,886 million from ¥272,530 million and net income increasing to ¥13,477 million from ¥11,112 million a year earlier. Despite higher sales and net income, basic earnings per share from continuing operations fell to ¥29.75 from ¥45.66, hinting at changes in share count or profit mix that matter for investors. Next, we examine how this mix of rapid sales expansion and lower earnings per share shapes...

Europe’s record heat is turning air conditioning from a luxury into critical infrastructure, and that shift is starting to influence where capital flows. As governments debate funding for cooling in hospitals and schools and push for greener, more efficient systems, some stocks exposed to this climate adaptation story could see fresh attention while others may face tougher questions. This article explores how the news-driven theme around European air conditioning expansion connects to three...

Shareholders will be ecstatic, with their stake up 35% over the past week following Saizeriya Co.,Ltd. 's ( TSE:7581...

Eisai (TSE:4523) is back in focus after fresh Alzheimer’s data and a new at-home dosing option for Leqembi. These developments together reshape how investors might think about the company’s neurology franchise. See our latest analysis for Eisai. Eisai’s latest Alzheimer’s updates arrive alongside a 12.12% 1 month share price return, though the share price is still down 7.04% year to date, while the 1 year total shareholder return of 16.39% contrasts with weaker 3 and 5 year total shareholder...

COSMOS Pharmaceutical Corporation recently reported full-year results for the year ended May 31, 2026, with sales of ¥1,099,583 million, net income of ¥32,046 million, and basic earnings per share of ¥404.33, alongside an increased annual dividend of ¥44.50 per share for fiscal 2026. At the same time, the company outlined lower year-end dividend guidance of ¥42.00 per share and issued detailed earnings forecasts for fiscal 2027, giving investors clearer visibility into expected sales,...

Tokyo Steel Manufacturing (TSE:5423) opened Q1 2027 with revenue of ¥72,927 million and basic EPS of ¥18.40, setting the tone for a period where trailing figures and recent quarters tell a mixed story on profitability. Over the last five reported quarters, revenue has moved between ¥60,032 million and ¥73,862 million while basic EPS has ranged from ¥8.19 to ¥47.11, giving investors a clear view of how earnings have tracked against a relatively tight revenue band. With trailing margins thinner...

Ichigo Inc. ( TSE:2337 ) shareholders are probably feeling a little disappointed, since its shares fell 2.7% to JP¥431...